Destiny Media Technologies Inc (DSNY) Q2 2026 Earnings Call Transcript

Why It Matters

The results underscore Waystar’s accelerating growth, AI‑centric revenue model, and successful acquisition integration, positioning it as a dominant platform in healthcare revenue cycle management and a bellwether for AI‑enabled financial automation.

Key Takeaways

• Q4 revenue $304M, up 24% YoY.
• Subscription revenue 55% of total, grew 38% YoY.
• AI drives 40% of 2025 revenue, 30% new bookings.
• Iodine acquisition adds 1,000 hospitals, 90% synergies by 2026.
• 2026 guidance targets 17% revenue growth, 42% EBITDA margin.

Pulse Analysis

Waystar’s latest earnings showcase a rare blend of high‑growth revenue and disciplined profitability. The company posted a 24% year‑over‑year revenue increase, driven by strong subscription sales and modest volume‑based gains, while adjusted EBITDA surged 29% to $129 million, surpassing its 40% margin target. With cash of $86 million and net leverage trimmed to roughly three‑times, Waystar is positioned to fund further innovation and strategic acquisitions without compromising balance‑sheet strength. The 2026 outlook projects 17% top‑line growth and a 42% EBITDA margin, reinforcing confidence in sustained organic expansion and cross‑sell momentum.

Artificial intelligence is now a core revenue engine for Waystar, contributing close to 40% of 2025 earnings and influencing 30% of new bookings. Its Altitude AI platform prevented $15 billion in claim denials and cut appeal times by 90%, delivering tangible ROI for providers. By embedding agentic AI across the revenue cycle—from pre‑bill anomaly detection to autonomous denial resolution—Waystar creates a high‑margin, sticky product suite that differentiates it from point‑solution competitors. This AI‑driven moat not only boosts gross margins but also fuels the company’s impressive net revenue retention of 112%.

The Iodine Software acquisition accelerates Waystar’s market reach, adding over 1,000 hospitals and health systems with minimal customer overlap, unlocking cross‑sell opportunities across both financial and clinical data domains. Integration is ahead of schedule, with more than 90% of the $15 million synergy target expected in 2026, enhancing profitability and expanding the addressable market. Combined with a network that processes 7 billion transactions annually and connects over a million providers, Waystar’s platform effect creates network effects that raise barriers to entry and support long‑term growth. Investors view these strategic pillars—AI leadership, acquisition synergies, and scale‑driven network effects—as key drivers of the company’s future performance.